CVS

CVS Health Corp

CVS, USA

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, medical spend management services, and other administrative services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.

https://www.cvshealth.com

Stock Price

$0.00

0%

decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
CVS
stock
CVS

Should You Buy CVS Health Stock Before Feb. 10? Yahoo Finance

Read more →
CVS
stock
CVS

Should You Buy CVS Health Stock Before Feb. 10? The Motley Fool

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

BUY

Target Price:

$94.6

Analyst Picks

Strong Buy

13

Buy

8

Hold

7

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Earnings Ratio (P/E)

-

Very Low

208.84

Low ≥ 50

High ≤ 10

Price to Book Ratio (P/B)

-

Very Low

1.40

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-5.45 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-1.56 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

0.10 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very Low

2.50

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 85.49% of the total shares of CVS Health Corp

1.

BlackRock Inc

(9.6731%)

since

2025/06/30

2.

Vanguard Group Inc

(9.4928%)

since

2025/06/30

3.

Dodge & Cox

(5.7784%)

since

2025/06/30

4.

Capital World Investors

(5.2796%)

since

2025/06/30

5.

State Street Corp

(4.6351%)

since

2025/06/30

6.

Dodge & Cox Stock I

(3.8021%)

since

2025/06/30

7.

FMR Inc

(3.5961%)

since

2025/06/30

8.

Vanguard Total Stock Mkt Idx Inv

(3.134%)

since

2025/07/31

9.

Vanguard 500 Index Investor

(2.4689%)

since

2025/07/31

10.

American Funds Washington Mutual A

(2.4181%)

since

2025/06/30

11.

Capital Group Wash Mutual Invtrs Comp

(2.4181%)

since

2025/06/30

12.

Geode Capital Management, LLC

(2.2577%)

since

2025/06/30

13.

JPMorgan Chase & Co

(2.1191%)

since

2025/06/30

14.

Capital Research & Mgmt Co - Division 3

(2.0807%)

since

2025/06/30

15.

Amvescap Plc.

(1.8554%)

since

2025/06/30

16.

American Funds Income Fund of Amer A

(1.7367%)

since

2025/06/30

17.

NORGES BANK

(1.553%)

since

2025/06/30

18.

American Funds American Balanced A

(1.4466%)

since

2025/06/30

19.

Morgan Stanley - Brokerage Accounts

(1.3653%)

since

2025/06/30

20.

Pzena Investment Management, LLC

(1.3204%)

since

2025/06/30

21.

T. Rowe Price Associates, Inc.

(1.3098%)

since

2025/06/30

22.

Fidelity 500 Index

(1.2643%)

since

2025/07/31

23.

SPDR® S&P 500® ETF

(1.2034%)

since

2025/08/31

24.

iShares Core S&P 500 ETF

(1.1987%)

since

2025/08/31

25.

Charles Schwab Investment Management Inc

(1.0867%)

since

2025/06/30

26.

Northern Trust Corp

(0.96%)

since

2025/06/30

27.

Davis Selected Advisers

(0.9135%)

since

2025/06/30

28.

Vanguard Value Index Inv

(0.884%)

since

2025/07/31

29.

Capital Group American Mutual Comp

(0.8032%)

since

2025/06/30

30.

American Funds American Mutual A

(0.8032%)

since

2025/06/30

31.

Bank of America Corp

(0.7694%)

since

2025/06/30

32.

UBS Asset Mgmt Americas Inc

(0.7393%)

since

2025/06/30

33.

Capital Research Global Investors

(0.7266%)

since

2025/06/30

34.

JPMorgan Equity Income I

(0.7145%)

since

2025/07/31

35.

JPM US Equity Income-Composite

(0.7145%)

since

2025/06/30

36.

The Health Care Select Sector SPDR® ETF

(0.6811%)

since

2025/08/31

37.

Vanguard Institutional Index I

(0.6029%)

since

2025/07/31

38.

American Funds Fundamental Invs A

(0.5747%)

since

2025/06/30

39.

Capital Group Fundamental Invtrs Comp

(0.5747%)

since

2025/06/30

40.

State St S&P 500® Indx SL Cl III

(0.5324%)

since

2025/08/31

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-12-31

EPS Estimate

0.9662

Latest Release

Date

2025-09-30

EPS Actual

1.6

EPS Estimate

1.36

EPS Difference

0.24

Surprise Percent

17.6471%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Potential Value Candidate(5)
Defensive
Moderately Defensive(4.5)
Dividend
Weak Dividend Profile(3)
Economic Moat
Some Competitive Advantage(5.8)
GARP
Not Attractive for GARP(2.5)
Growth
Weak Growth Prospect(3)
Momentum
Moderate Momentum(6)
Net Net
Not Undervalued (Net-Net)(2.5)
Quality
Low Quality Business(3)
Value
Fair Value(4)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.